GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
Best not assume it's not already been signed off eh? ;)'
Well Should be closer by Monday :)
'The Critical Raw Materials Act is now expected to be voted in the European
Parliament’s plenary on 11 September, opening the way for final “trilogue” talks with EU member states and the European Commission to approve the legislation.'
And as if that were not enough... Pulawy positive ..
'Increased goals for EU refining and processing capacity
On Thursday, lawmakers also voted to increase the EU’s goal for domestic refining and processing capacity of critical raw materials, raising it from 40% to 50%. This is in line with the demands of EU countries, which supported the same objective during a vote on 30 June.
In addition, members of Parliament introduced a new benchmark “so that the Union consumes less Critical Raw Materials than predicted in a reference scenario,” Hahn said.'
'The EU will aim to recycle at least 45% of each “Strategic Raw Material” contained in the Union’s waste under plans voted on by the European Parliament’s industry committee on Thursday (7 September).
The new recycling goals were voted on as part of the Parliament’s position on the Critical Raw Materials Act, which aims to reduce the bloc’s dependency on China and other countries for key metals like rare earths.'
https://www.euractiv.com/section/circular-economy/news/parliament-raises-recycling-goals-in-eu-critical-raw-materials-act/
It'll be the likes of Berm who post the CIMT conference posters here when they are released soon pre-conference and help explain what their content means
You should value that and not some boring clowns who add nothing to the BB or worse and don't even have entertainment value!
I'm done with this BB I am well capable of doing my own research and must thank Lindy for that disaster RNS that has really caused all this as it changed my focus and portfolio and I've found I'm quite good at now making gains from doing just that research and knowing how to value others research that they put out ...
Seems some still need me here as some bogeyman though:) too bad but my powers will still work from afar lol.... well my mistake was I proffered a view with some relevant info that did have an sp effect (the info not my view,I hope) good to see the bounce back though...One partial response that has gone progressive out of 24 fully dosed patients most of whom are no longer on trial does not read commercial to me seeing as tumor reduction was what modi was all about and is the gold standard of success (personal opinion that)... better to shift focus to SCIB1 like Scancell are doing
Again all a learning process I've been honest and told my story ... I regret not cashing in Covid play SP success and piling the lot into BioNTech even though I knew that company was a winner! Duh... I've had to think about my thinking there lol
Berm writes so much better than me (I confuse myself sometimes) and there are many others here who add great research value to the BB I guess some things are simply off-topic whilst the sp is so volatile, I get it ...
So see you all at the 'crumbsgate' arms:) for the £1 party yes it's still possible! £8 is probably a stretch now though:( if that does happen that party will be a better venue! Many strings to the bow and great to see the new signing whom we knew was coming due to valuable share relevant researchers on here! Please carry on!
Ruck you owe me a 7p pint :)
Roadshow... Dunno if anyone here got to go to the SusMagpro roadshow as part of The Birmingham REE event but here is a vid of one of their displays of recycled by HyproMag tech batteries.... vid starts fast then goes into MDA wait mode then speeds up again... hopefully much like SP here :)
https://twitter.com/bhamenergy/status/1699748518221549765
Big thanks to all who did their due diligence and research and shared it here and elsewhere I only bought in earlier this week after a weekend research dive
It looks like it will do really well on the NASDAQ away from the AIM casino... looking forward to next week :)
It's not 'write off' it's 'sign off'... Mkango will sign it off when it suits them and whoever it is partner-wise that is going to be funding the mine and Malawi will sign it off when it suits them too ... Be interesting what Lotus now do with Uranium on the rise...
I appolgse for having the gall to ask for a company Q&A to clear up some issues forgot there are no issues... people seem to miss I say SCIB1 looks commercial...if modi1 gets the data in CPI to back it up it could get a PH2 I appreciate Johhnys post 2 patients known there both looking to have a beneficial response....Sadly you can't question anything here without being deemed a maniplaor but I guess thats of scancells making they sure have kept the risk half of the risk reward ratio very high...due to partnering nothing .... anyways I'm giving it a rest as small beans this for me now and can always increase on positives and not suffer too much from those collapsing sp days...there is no sensible discussing anything here at the moment....Let the links to none scancell relevant content and posts by those who don't even know a moditope from a potato fill the BB
...
Yeah glad to clear that up you are right Clatterbridge have mRNAs in trial with some promising results CW likes to link to them without maybe wondering are these more attractive rivals for pharma bucks..also seems thinking of how scancell may bring the trial to a close and manage shareholders if there is to be no ph2 ....is a non topic too oh well scancell may give us that Q&A ive been asking them for after CIMT otherwise it could be construed as them hiding from their shareholders .... onwards 🙂
CW a fear to me is a fear to me ...not to you...it couldn't be any clearer! An arm of the trial breast CPI was dropped they didn't report on data in all the mono doses patients they had data for...now SCIB1 is being brought to the fore.....geez it's not hard plus we all know most cancer vaxs do fail.....but until CPI data is in I agree there is still hope but in latestage mono....To ME only ME one random investor modi 1 is not looking commercial....hope that makes it t clear now go link to some therapy that does look like it's going commercial and make our that means scancells are too 😜
Ivy my line about mRNA was in regards to winning the Covid vax race commercially therefore meaning Covidity was too late in the race to be taken up.....it wasn't meant as mRNA is the answer
That's more reassuring Johnny....it could well be CPI is the key... I'm probably psychological preparing for worst as it seems to me at least there is a potency issue.... again I think they can overcome that with science but that's time and money.....all will be revealed and if it does start to look more commercial to me I can buy up my holding.... anyways enough of that... looking forward to SCIB1 update
See, isn't that better thanks Chester and WTP, and for your benefit of the doubt WTP :) .... I've made far more shares-wise from acting on research info than being some game player and that is all I'm guilty of here sharing info that was coming anyways... Sweden going Nuclear and lifting the uranium mining ban is my current smart move that paid off....
There was once here much speculation in the long wait for Covidity results that it was probably a dud I was on the side of no... it'll be doing the business but it probably won't do the business commercially due to mRNA winning already BioNtech and Moderna won...Though that product potential remains
I agree the tumour reduction is not 'nothing' and indeed 'stable' is not nothing...
But my feeling... Our very first patient on a full mono dose turned out by a fluke of statistics to be the best responder and this was why Lindy was so optimistic early on.... also as we know that response has now reversed...why? dunno we all know Cancer is such a hard beast to beat and not only does that have so many tricks evolved to evade the immune system but the immune system itself can be against therapies... so probably it is a combination of that...I know team scancell science can science this to the max... my only worry is ... the commercial aspect I'd say the part of the trial that is in and over Ovarian is now going nowhere commercially speaking... Certainly, there was no ... partner now sought part of that RNS it's a case of maybe CPIs will open a door there if they show efficacy in Renal and head and neck... ( breast dropped)... Okay, so there is a fear for me Is the trial being sought of wound down? again I don't know and it depends on the CPI cohort and resected cohorts we until now only have one patient's worth of info there... a reduction but is it only 1mm ? It's not to my mind what modi 1 ought to be showing! ... And was never sold as much... The 'de-risking' quote in Trinity I dunno maybe that is a positive sign?
Again that's just my personal thinking on it and Modi is but one string of the bow update on SCIB1 soon... multiple shots on goal
"One head & neck patient achieved a partial response and remains on study at week 37."
You will see that information was already reported in the Business update SP sinking RNS old news... that patient we now know is no longer on the trial like most if not all the other mono patients we know of... I get shot for this but to me, the mono trial is not looking.... commercial (totally accept others' opposite view on that and their reasonings)...to me, they kind of say so with the CPI comments in the Trinity report fingers crossed that finds the sweet spot, maybe it should have been the first cohort recruited if it were the most likely of success, possibly the Mc site combo patient is the one in that cohort reported with a tumor regression? ....
And it is great to report successful Immuno successes at Clatterbridge that are not Scancell techs but remember they are also commercially speaking.... rival treatments ...who gets the pharma deal?
The best thing about the Trinity report IMHO... the shift back to SCIB1 ...ImmunoBody .... I reckon that is showing good results... though we don't know that till the update We already have SCIB1 data that showed its effectiveness and now with Pharmajet and AvidiMab... great commercial potential ...See a positive!
So that is just my take after hours so my market magic of pointing some share relevant information does not somehow influence SP and benefit my amazing nefarious trading skills:)) (still a little underwater here )) But my bestie Ahavenoidea will buy us back into the tens... I'd prefer good solid commercial newsflow did that though.. to take the pressure off him and co :)
And it is indeed best to DYOR ... or you may well end up being in a share where you have no idea what it is they do ;p
Cheers Aha my best new mate :) you have found me out!
TBF I 'am sitting in a boilering room but that is just because there is no Aircon
Think you will find I gave and give no advice in buying and selling its up to each individual what to with the information out there ... Nice to see the timely Trinity report still a ways to go to hit their target price and some of the news in there is we now know already dated (sadly)
Please have a go at me as much as you like I'm made for it... but don't bring the Trial patients into it that is well.... sick
x
Scancell does have a paper about how antigen-specific T Regs may hinder effectiveness of the vax
'Modified antigens maybe a good target for anti-tumor immunity
but cancer patients have a specific LAP+ regulatory population
which would either need to be inhibited with a LAP/TGF-β
neutralizing antibody or polarized to Th1 with vaccination.'
https://www.scancell.co.uk/Data/Sites/1/media/publications/posters/paris-lap-poster.pdf
One thing is for sure, Team Scancell can Science the best out of the moditope platform... can they afford to though .... Needs ... always needed a partner
WTP writing was on the wall with the disaster RNS at first I think like yourself I read the positives in it only to begin seeing the negatives and when people pointed out what was missing modi 1 wise... bells rang and I took the action to save my capital... its that simple really and yes I then bought up a much smaller holding from the lows... I'm no trading genius I sat on 28p over 100% up when I shouldn't have ...But one thing was for certain I was never going to be sat underwater for what seemed like an eternity which happened after AGM of doom and decent to 3p ... you learn I guess..
So again this ought to be a bio unicorn why its failed to become one so far.... you tell me...
What I will say is to me and that is just me you can all make your own minds up! modi 1 is not looking commercial... that doesn't mean moditope is a write off but it needs work and work needs money
so... ImmunoBody and GlyMabs AvidiMab it is